21 results

• BioZorb Lawsuits Over Breast Marker Complications Set for Trial in Sept. 2025 and Jan. 2026

  January 22, 2025

  Irvin Jackson

  A federal judge has set the first two dates for BioZorb lawsuit bellwether trials, with the first claims slated to go before juries Sept. 8, 2025 and Jan. 20, 2026.

• Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment

  January 9, 2025

  Irvin Jackson

  In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

• BioZorb Lawyers Propose Four Lawsuits Over Recalled Tissue Marker To Prepare for Trials Starting in Sept. 2025

  December 23, 2024

  Irvin Jackson

  A group of four BioZorb lawsuits have been selected for early bellwether trials, which are expected to begin in September 2025.

• BioZorb Marker Lawsuits Involving 100 Different Plaintiffs Pending in District of Massachusetts

  December 12, 2024

  Irvin Jackson

  Lawsuits allege that recalled BioZorb Markers failed to absorb into the body after breast cancer treatments, resulting in painful complications and the need for additional medical procedures.

• Hologic Seeks To Dismiss BioZorb Design Defect Claims in Lawsuits Over Recalled Tissue Marker

  November 14, 2024

  Irvin Jackson

  Although a BioZorb recall has been issued for all versions of the breast tissue markers sold by Hologic, the manufacturer is asking a federal judge to throw out lawsuits alleging that injuries were caused by design defects.

• BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal

  November 7, 2024

  Irvin Jackson

  Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.

• Hologic Faces Lawsuit Over BioZorb Complications Experienced by Five Breast Cancer Patients

  October 24, 2024

  Irvin Jackson

  A group of breast cancer survivors from across the country have filed a lawsuit against Hologic, indicating that a BioZorb marker left them with infections, scarring and other complications.

• Lawsuit Alleges BioZorb Removal Surgery Likely Needed After Breast Tissue Marker Failed To Reabsorb

  October 10, 2024

  Irvin Jackson

  Breast cancer survivor indicates that her chemotherapy tissue marker BioZorb failed to absorb into her body, resulting in severe pain and the need for surgery to remove the implant.

• Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

  September 4, 2024

  Irvin Jackson

  Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.

• BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

  August 14, 2024

  Irvin Jackson

  A group of four lawsuits over the BioZorb marker will be selected for a series of early bellwether trial dates starting in July 2025, which are designed to help gauge how juries may respond to evidence that will be repeated throughout claims that the tissue marker caused painful complication.